<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Online Pharmacy Canadian Online Pharmacy &#187; Plan-B</title>
	<atom:link href="http://www.thecanadianonlinepharmacy.com/tag/plan-b/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thecanadianonlinepharmacy.com</link>
	<description>Online Pharmacy Canadian Online Pharmacy</description>
	<lastBuildDate>Sat, 27 Mar 2010 04:57:13 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>single-dose Plan B, Teva touts advantages</title>
		<link>http://www.thecanadianonlinepharmacy.com/2009/08/single-dose-plan-b-teva-touts-advantages/</link>
		<comments>http://www.thecanadianonlinepharmacy.com/2009/08/single-dose-plan-b-teva-touts-advantages/#comments</comments>
		<pubDate>Fri, 07 Aug 2009 04:04:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[I-Pill]]></category>
		<category><![CDATA[levonorgestrel emergency contraceptive]]></category>
		<category><![CDATA[Plan B ipill]]></category>
		<category><![CDATA[Plan-B]]></category>
		<category><![CDATA[single-dose Plan B]]></category>
		<category><![CDATA[unprotected sex]]></category>

		<guid isPermaLink="false">http://www.thecanadianonlinepharmacy.com/?p=36</guid>
		<description><![CDATA[Teva Pharmaceutical Industries has recently received approval from the US FDA to market its emergency contraceptive Plan B (levonorgestrel) in a new dosage formulation that requires a single 1.5mg tablet, instead of two 0.75mg tablets which need to be taken 12 hours apart. Teva touts as an advantage the fact that the new formulation, Plan B One-Step, can be taken "right away" after unprotected sex has occurred. It is known that Emergency contraception is more effective the sooner it is taken. Plan B One-Step is expected to be in retail pharmacies in August, Teva said. The new formulation will replace the two-pill formulation in Teva's product line just as the original Plan B product loses its US exclusivity (as an OTC product) on August 24th. Pricing of the new single-tablet formulation has not been announced, but industry observers believe it might be similar to the original Plan B product, which costs $49.99 on the on-line retailer drugstore.com. In addition to approving the single-dose emergency contraceptive, the FDA has also expanded OTC access to both Plan B One-Step and the original two-dose Plan B]]></description>
			<content:encoded><![CDATA[<p><span id="more-36"></span><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> </w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" LatentStyleCount="156"> </w:LatentStyles> </xml><![endif]--><!--[if !mso]><span class="mceItemObject"   classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></span><br />
<mce:style><!  st1\:*{behavior:url(#ieooui) } --></p>
<p><!--[endif]--> <!--[if gte mso 10]><br />
<mce:style><!   /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin:0in; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:10.0pt; 	font-family:"Times New Roman"; 	mso-ansi-language:#0400; 	mso-fareast-language:#0400; 	mso-bidi-language:#0400;} --></p>
<p><!--[endif]--></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size: 10pt; font-family: Arial;">This double dose <strong>plan-B</strong> is already available in India. You will already find it listed in our Price List (www.genericmedicine.com). </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size: 10pt; font-family: Arial;">Supplied Product Name-<strong> iPill</strong> (1.5mg tablet) from <strong>Cipla</strong> Ltd, India. </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size: 10pt; font-family: Arial;"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size: 10pt; font-family: Arial;">As FDA approves <strong>single-dose Plan B</strong>, Teva touts advantages </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size: 10pt; font-family: Arial;">17 July 2009 by Nancy Faigen </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"><span style="font-size: 10pt; font-family: Arial;"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"><span style="font-size: 10pt; font-family: Arial;">Teva Pharmaceutical Industries has recently received approval from the US FDA to market its <strong>emergency contraceptive Plan B (levonorgestrel)</strong> in a new dosage formulation that requires a single 1.5mg tablet, instead of two 0.75mg tablets which need to be taken 12 hours apart. Teva touts as an advantage the fact that the new formulation, <strong>Plan B</strong> One-Step, can be taken &#8220;right away&#8221; after <strong>unprotected sex</strong> has occurred. It is known that <strong>Emergency contraception</strong> is more effective the sooner it is taken. <strong>Plan B</strong> One-Step is expected to be in <strong>retail pharmacies</strong> in August, Teva said. The new formulation will replace the two-pill formulation in Teva&#8217;s product line just as the <strong>original Plan B</strong> product loses its US exclusivity (as an OTC product) on August 24th. Pricing of the new single-tablet formulation has not been announced, but industry observers believe it might be similar to the original <strong>Plan B</strong> product, which costs $49.99 on the on-line retailer drugstore.com. In addition to approving the <strong>single-dose emergency contraceptive</strong>, the FDA has also expanded OTC access to both <strong>Plan B One-Step</strong> and the original two-dose <strong>Plan B</strong>, and will make them available to consumers age 17 or older. The FDA said in April it would provide no objections to a judge&#8217;s order to allow the OTC sales to 17-year olds (scripnews.com, April 24th, 2009). Both products will be available for women younger than 17 years of age only by prescription. Many healthcare workers view the original <strong>Plan B</strong> product as posing limitations, because it requires careful timing that may not be convenient for a patient.<strong> Jennifer Rogers</strong> who is the acting executive director for Reproductive Health Technologies Project, told Newsweek, &#8220;Sometimes, with two doses, women would delay taking their first pill. If you buy it at 2pm, but don&#8217;t want to wake up at 2am, you may wait another six hours to begin the course of treatment.&#8221; She added, &#8220;For us, one pill makes the most sense.&#8221;The US data sheet for <strong>Plan B</strong> One-Step outlines the clinical efficacy of the new formulation. It states: &#8220;In the <strong>Plan B</strong> Step-One group, 16 pregnancies occurred in 1,198 women and in the <strong>Plan B</strong> group, 20 pregnancies occurred in 1,183 women. The number of pregnancies expected in each group was calculated based on the timing of intercourse with regard to each woman&#8217;s menstrual cycle. Among women receiving <strong>Plan B</strong> One-Step, 84% of expected pregnancies were prevented and among those women taking <strong>Plan B</strong>, 79% of expected pregnancies were prevented. The expected pregnancy rate of 8% (with no <strong>contraceptive</strong> use) was reduced to approximately 1% with <strong>Plan B</strong> One-Step.&#8221; Last month, the FDA approved the first ANDA for the two-dose formulation, from Watson Laboratories. Watson plans to launch its generic product shortly, under the trade name Next Choice. For now, its two-dose 0.75mg formulation will only be available by prescription. Visit genericmedicine.com to buy this product</span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"><strong><span style="font-size: 10pt; font-family: Arial;">Buy double dose plan-B </span></strong><span style="font-size: 10pt; font-family: Arial;">from www.genericmedicine.com</span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecanadianonlinepharmacy.com/2009/08/single-dose-plan-b-teva-touts-advantages/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
